Skip to main content

2022 CTOS Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Amy M. Weise, DO

Barbara Ann Karmanos Cancer Institute, Karmanos Cancer Institute
Detroit, Michigan, United States

Presentation(s):

Paper 20 - SUSTAINED DISEASE CONTROL WITH MDM2 INHIBITOR MILADEMETAN IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA
Thursday, November 17, 2022
1:24 PM – 1:32 PM